ALA 1.61% 15.3¢ arovella therapeutics limited

Ann: FY20 Annual Report to shareholders, page-3

  1. 362 Posts.
    lightbulb Created with Sketch. 278
    “Dr Michael Baker was granted a performance bonus of $53,625; it related to the 2020 financial year and included in the remuneration disclosure for 2020. It was paid in August 2020.”

    SUD share price day Baker was appointed $0.051 (02/01/20)
    SUD share price at 30/6/20 $0.031.

    40% deterioration in SP performance in the six months since he started - that’s worthy of a $50k bonus??! Good to see CR proceeds are being directed to the right cause.

    Jesus imagine if the SP had gone up, we’d be bankrupted.

    We should probably all have a really good think about approving this years director remuneration resolutions for the AGM - depending on what grandiose proposals they make for each (gifting low priced options and throwing them around like they’re confetti not going to cut it his time boys) - I’d urge all shareholders to put the time into considering what they are actually granting these guys.

    We’re all in this to make money, and these guys only continue to deliver losses.
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.